The Health Department is offering the Clinical Trial Readiness Grant for Rare Diseases to support clinical projects aiming to enhance clinical trial readiness in rare diseases. This grant is designed to facilitate rare disease research, improve the movement of candidate therapeutics towards clinical trials, and increase the success rate through the development and testing of biomarkers, clinical outcome measures, and defining disease presentations. Researchers are invited to submit proposals to advance the field of rare disease research before the closing date on October 25, 2021.
Opportunity ID: 309420
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-18-953 |
Funding Opportunity Title: | Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health Income Security and Social Services |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.350 — National Center for Advancing Translational Sciences |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Oct 04, 2018 |
Last Updated Date: | – |
Original Closing Date for Applications: | Oct 25, 2021 |
Current Closing Date for Applications: | Oct 25, 2021 |
Archive Date: | Nov 30, 2021 |
Estimated Total Program Funding: | – |
Award Ceiling: | $200,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments City or township governments State governments Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Special district governments Native American tribal governments (Federally recognized) Independent school districts Small businesses |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in rare diseases. The initiative seeks applications that are intended to facilitate rare disease research by enabling efficient and effective movement of candidate therapeutics or diagnostics towards clinical trials, and to increase their likelihood of success through development and testing of rigorous biomarkers and clinical outcome assessment measures, or by defining the presentation and course of a rare disease to enable the design of upcoming clinical trials. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-953.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-E | Use for due dates on or before May 24, 2020 | PKG00245404 | Dec 07, 2018 | May 24, 2020 | View | |
FORMS-F | Use for due dates on or before January 24, 2022 | PKG00259924 | Dec 07, 2018 | Jan 24, 2022 | View |
Package 1
Mandatory forms
309420 RR_SF424_2_0-2.0.pdf
309420 PHS398_CoverPageSupplement_4_0-4.0.pdf
309420 RR_OtherProjectInfo_1_4-1.4.pdf
309420 PerformanceSite_2_0-2.0.pdf
309420 RR_KeyPersonExpanded_2_0-2.0.pdf
309420 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
309420 RR_Budget_1_4-1.4.pdf
309420 RR_SubawardBudget30_1_4-1.4.pdf
309420 PHS398_ModularBudget_1_2-1.2.pdf
309420 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
309420 RR_SF424_2_0-2.0.pdf
309420 PHS398_CoverPageSupplement_5_0-5.0.pdf
309420 RR_OtherProjectInfo_1_4-1.4.pdf
309420 PerformanceSite_2_0-2.0.pdf
309420 RR_KeyPersonExpanded_2_0-2.0.pdf
309420 PHS398_ResearchPlan_4_0-4.0.pdf
309420 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
309420 RR_Budget_1_4-1.4.pdf
309420 RR_SubawardBudget30_1_4-1.4.pdf
309420 PHS398_ModularBudget_1_2-1.2.pdf
309420 PHS_AssignmentRequestForm_3_0-3.0.pdf